Logo

BMS

Rancho Biosciences Launches Single-Cell Data Science Consortium With Pharma Firms

BMS, J&J, Novartis, and Vesalius will work with the bioinformatics firm to develop standards for creating and using single-cell datasets for drug discovery.

Integrated Tumor, Microbiome Features Influence Immunotherapy Combo Effects in Advanced Melanoma

Gut microbiome features showed ties to treatment response and immune-related adverse events in advanced melanoma patients on a combined checkpoint blockade treatment.

Tempus, Bristol Myers Squibb Expand Cancer Biomarker Alliance

Tempus has been providing Bristol Myers Squibb with de-identified transcriptomic datasets to help in the identification of new cancer biomarkers.

Invitae, Pharma Firms Partner to Develop Standard MRD Panel for AML Clinical Trials

Invitae is working with Bristol Myers Squibb, Janssen, Novartis, and Genentech to advance an NGS panel to gauge the efficacy of AML treatments in trials.

Illumina CEO Discusses Pan-Cancer IVD Assay, CDx Collaborations at JP Morgan

The firm also provided preliminary revenues of $950 million for Q4 and reinstated guidance of $3.79 billion to $3.88 billion for 2021.

Jan 11, 2021

Grail Inks Deals With Amgen, AstraZeneca, Bristol Myers Squibb for MRD Test Development

Dec 9, 2020

Nonprofit Friends of Cancer Research Launches Public-Private HRD Harmonization Project

Dec 7, 2020

UK Biobank Collaborating With Biopharmas to Profile Plasma Proteome of 53K Subjects

Nov 5, 2020

Paradigm4 Moves Into Single-Cell Data, Helps Pharma Address COVID-19
Premium

Aug 10, 2020

T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma

Jul 27, 2020

Oncology Informatics Firm Vidence Emerges to Supply Real-World Clinical, Genomic Data to Researchers
Premium

Jul 15, 2020

ReviveMed, Bristol Myers Squibb to Study Metabolomics for Cancer Immunotherapy

Jun 18, 2020

ArcherDx, Bristol Myers Squibb Partner on Minimal Residual Disease Monitoring

Mar 4, 2020

Pulmonary Fibrosis Foundation, Celgene Form Biomarker Consortium

Jan 22, 2020

B Cell Gene Expression Profiling May Enable Cancer Immunotherapy CDx Test
Premium

Dec 9, 2019

PAK4 Inhibition Increases Anti-PD-1 Response in Mouse Models Prompting Phase I Trial

Mar 13, 2019

Quantabio Pairs Rapid Thermal Cycler, Proprietary Reagents for Fast NGS Library QC
Premium

Mar 12, 2019

Biocartis Inks Cancer CDx Deal With Bristol-Myers Squibb

Dec 18, 2018

Bristol-Myers Squibb, Boston Medical Center Partner to Study Immuno-Oncology Response, Resistance

Dec 17, 2018

Bristol-Myers Squibb, H3 Biomedicine Form Cancer Immunotherapy Alliance

Oct 30, 2018

Precision Oncology Highlights From ESMO 2018

Oct 9, 2018

PGDx Liquid Biopsy Assay to be Used in Cancer Drug Study

Sep 13, 2018

Bristol-Myers Squibb to Use Natera's Cell-Free DNA Assay in Immunotherapy Study

May 23, 2018

Two Initiatives Seek to Harmonize Tumor Mutational Burden Testing
Premium

Apr 17, 2018

At AACR, Immuno-Oncology Clinical Trials Offer Mixed Messages on Predictive Biomarkers
Premium

Breaking News
The Scan

UK Moves to Allow Sale of Gene-Edited Food

The UK is moving ahead to allow the sale of gene-edited food in England, Scotland, and Wales, according to New Scientist.

Questions for the Field

Stat News writes that the alleged Buffalo shooter's citation of genetics research raises questions about what the field can do.

Cell Studies on Tumor Evolution in Mouse Model of Lung Cancer, Stereo-seq, Bacteriophage Responses

In Cell this week: tumor evolution tracked in mouse model of lung cancer, organogenesis mapped using Stereo-seq, and more.

Taking Stock of the Stockpile

The US and European countries are evaluating their smallpox vaccine stockpiles as the number of monkeypox cases increases, the Washington Post reports.